MedPath

Assessment Crestal Maxillary Sinus Membrane Elevation Using Different Implant Heights

Phase 1
Conditions
Bone Formation Around Implant After Crestal Sinus Lifting
Interventions
Procedure: trans-crestal sinus lifting
Registration Number
NCT05166434
Lead Sponsor
Cairo University
Brief Summary

This study is aiming to evaluate primary stability and bone gain in trans-crestal osseodencification technique using Regular concaved osteotomes at different height elevations.

Detailed Description

For those patient who need up to 2-6 mm of vertical height, the 1-stage transcrestal osteotome technique shown to be stable over long term.

The most important negative factor that can be inferred from the results is that BAOSFE becomes less predictable when there is 4 mm or less of preexisting alveolar bone height beneath the sinus. Moreover, more challenging situation is the magnitude of tapping force, which may accidently perforate the antral membrane causing a lot of complication in the naso-antral apparatus by excessive taping force. The expansion of the osteotomy sites is performed with a number of Concave tipped tapered osteotomes with increasing diameters that are applied through the edentulous alveolar crest at the inferior border of the maxillary sinus floor. With each insertion of a larger osteotome, bone is compressed, pushed laterally and apically while pushing the garnered bone apically beneath the tented membrane.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Patients with edentulous vertically deficient posterior maxillary ridge a minimum 4 mm height of alveolar bone, and 6 mm in width.
  • Both males as well as females without any active periodontal disease.
  • All patients are in a good health with no systemic, immunologic or debilitating diseases that could affect normal bone healing.
  • All selected patients are non-smokers and non-alcoholics.
  • Patients are free from T.M.J troubles, abnormal oral habits such as bruxism.
  • The edentulous ridges are covered with optimal thickness of mucoperiosteum with no signs of inflammation, ulceration or scar tissue.
  • Remaining natural teeth have good periodontal tissue support and occlusion showed sufficient inter arch space for future prosthesis.
Exclusion Criteria
  1. On the local level, patients with maxillary sinus diseases, former sinus surgery and unfavorable inter maxillary relationship will be excluded.
  2. General contraindications to implant surgery.
  3. Subjected to irradiation in the head and neck area less than 1 year before implantation.
  4. Untreated periodontitis.
  5. Poor oral hygiene and motivation.
  6. Uncontrolled diabetes.
  7. Pregnant or nursing.
  8. Substance abuse.
  9. Psychiatric problems or unrealistic expectations.
  10. Severe bruxism or clenching.
  11. Immunosuppressed or immunocompromised.
  12. Treated or under treatment with intravenous amino-bisphosphonates.
  13. Lack of opposite occluding dentition/prosthesis in the area intended for implant placement.
  14. Active infection or severe inflammation in the area intended for implant placement.
  15. Need of bone augmentation procedures at implant placement.
  16. Unable to open mouth sufficiently to accommodate the surgical tooling.
  17. Patients participating in other studies, if the present protocol could not be properly followed.
  18. Referred only for implant placement or unable to attend a 5-year follow-up.
  19. Requiring only single implant-supported crowns.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
bone formation around implant at 2mm membrane elevation crestal sinus liftingtrans-crestal sinus lifting-
bone formation around implant at 6mm membrane elevation crestal sinus liftingtrans-crestal sinus lifting-
bone formation around implant at 4mm membrane elevation crestal sinus liftingtrans-crestal sinus lifting-
Primary Outcome Measures
NameTimeMethod
Measuring bone formation and density beyond apical part of dental implant after closed sinus lifting4 months after Dental implant placement

CBCT superimposition of the Pre-operative and Post-operative

Secondary Outcome Measures
NameTimeMethod
Measuring secondary stability of dental implants4 months after Dental implant placement

osttell device (ISQ)

Trial Locations

Locations (1)

Maher Mohammed Hebah Maqbol

🇪🇬

Cairo, Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath